Osiris Therapeutic

Osiris Therapeutics’s Buy Rating Reiterated at Piper Jaffray (OSIR)

Piper Jaffray restated their buy rating on shares of Osiris Therapeutics (NASDAQ:OSIR) in a research notereleased on Thursday morning, Market Beat reports. Piper Jaffray currently…